RECRUITING Not applicable ClinicalTrials.gov

Finding Immune Nascent Type 1 Diabetes

Sponsor: Indiana University • ClinicalTrials.gov ID: NCT07663136

Registry updated: 2026-10-02

Recruiting for Similar Conditions?

Sponsors are looking for patients like you. See if you qualify for compensated research studies.

Description

The goal of this clinical trial is to understand how many individuals who previously participated in the Indiana Biobank will return a type 1 diabetes home screening kit based upon different methods of recruitment communication. The main question it aims to answer is: What form of recruitment communication is most effective for completing a type 1diabetes home screening kit? Researchers will compare two types of recruitment contact: email and mail based communication (low-touch) versus phone contact and follow-up by a research team member (high-touch). Participants will be contacted either via email/mail or by phone and asked if they want to complete a type 1 diabetes home screening kit.

Interventions

phone call (Behavioral)
Recruitment through phone call
email/mail (Behavioral)
Recruitment through email and mail

Eligibility criteria

Inclusion Criteria: * Participant must be in Indiana Biobank * Participant must be able to provide consent * Ages 1-99 including pregnant women Exclusion Criteria: * Refusal to sign informed consent for home screening is exclusionary for the home screening portion of the study * While other medical conditions are allowable prior diabetes diagnosis is exclusionary for home autoantibody screening

Conditions

Healthy Adult Type 1 Diabetes (T1D)

Locations

Indiana University School of Medicine — Indianapolis, Indiana, United States

Partner with Nurenyx

Showcase your study to thousands of motivated patients matching your criteria.

Learn More

Official Source

Data sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

View Official Record

Accelerate Your Clinical Trial Recruitment